Skip to main content
Clinical Trials/NCT04153708
NCT04153708UnknownNot Applicable

A Clinical Trial to Evaluate the Efficacy of Two Strategies to Linkage to Care Patients With Hepatitis C Lost to Follow-up

University of La Laguna2 sites in 1 country352 target enrollmentStarted: November 3, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
352
Locations
2
Primary Endpoint
Acceptance of the intervention

Study Overview

Brief Summary

The main purpose of the study is to compare the efficacy of two strategies aimed to rescue patients lost to follow-up with active infection or with positive HCV antibodies without RNA request to complete evaluation and prescription of treatment in cases of chronic infection. After patient identification from data files of laboratory and microbiology charts, patients will be randomized to: a) phone call, and b) invitation letter, both of two strategies including a scheduled appointment with the hepatologist.

Detailed Description

This is a prospective, randomized study in which subjects lost to follow-up with positive HCV antibodies without RNA request or positive RNA will be proposed to be brought back into care.

After patients identification from data files of laboratory and microbiology charts using three different cohorts in time (2005-07, 2011-11 and 2015-17), eligible patients (18 years of age or older, patients positive for HCV antibodies without RNA request or positive RNA lost to follow-up, with a valid sanitary card in our public health system and with available data for contact) will be randomized to: a) phone call (Strategy 1), and b) invitation letter (Strategy 2), both of two strategies including a scheduled appointment with the hepatologist.

Strategy 1 includes until three phone calls to contact patients and provide them with an appointment with the hepatologist (tertiary care center) over a period of 14 days according to patient availability. Instead, strategy 2 includes an invitation letter providing patients with the appointment with the hepatologist over a same period of time than strategy 1. If there is no response to calls or no attendance to the appointment after the letter (randomized strategy), the strategy will be switched to the another one.

Epidemiological, clinical, and laboratory variables will be registered.

The hypothesis of the study is that phone calls will improve the rate of linkage to care among HCV patients lost to follow-up compared to the invitation letter shipment. Therefore, call would be an effective strategy to rescue these patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years of age or older
  • Record of positive HCV antibodies without RNA request or positive RNA lost to follow-up (non-treated patients with an active infection, without surveillance by any HCV specialist)
  • Patients a valid sanitary card in our public health system
  • Patients with available data for contact)

Exclusion Criteria

  • Belong to another catchment area. Current surveillance by any HCV specialist and/or record of sustained virological response.
  • Severe comorbidity with an expected survival lower than 1 year.

Outcomes

Primary Outcomes

Acceptance of the intervention

Time Frame: One month after the intervention

Number of patients and % attending the clinic (linkage to care rate)

Secondary Outcomes

  • Viability of the intervention(1 week)
  • Effectiveness of the intervention(6 months after starting treatment)
  • Factors associated with viability of the strategies(6 months)

Investigators

Sponsor
University of La Laguna
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Manuel Hernandez-Guerra, MD

Principal Investigator

University of La Laguna

Study Sites (2)

Loading locations...

Similar Trials